[DIV28SUPER] NYTimes: Selling a Poison by the Barrel: Liquid Nicotine for E-Cigarettes

http://nyti.ms/OPTavk

"E-liquids" used to refill e-cigarettes are potent, unregulated neurotoxins. Evidence of the potential dangers is already emerging.

#div28
___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

[DIV28M] Highlighting PsycCRITIQUES blog posting "Don=?Windows-1252?Q?=92t?= Worry, Be Happy, Try These Pills"

This notice has been sent on behalf of Danny Wedding, editor of APA's online book and film review journal PsycCRITIQUES. APA developed a PsycCRITIQUES blog that makes it possible for interested psychologists around the world to read selected book and film reviews and comment on the issues raised in those reviews.  We think this week's blog posting, entitled "Don't Worry, Be Happy, Try These Pills" about the book "Happy-People-Pills for All" would interest members of Division 28.

 

For the coming week, this blog posting is on the home page at http://psyccritiquesblog.apa.org/ (afterwards, it will be found in our Recent Posts list or our Archives).

At this site you can review the blog and make comments (click on the red comments button at the bottom of the probe).

We would welcome your comments to this blog posting, or any previous postings you may find of interest in our archives. You can also subscribe to all new blog posts via email and web-based news readers at http://feeds2.feedburner.com/PsycCRITIQUESBlog .

 

Regards,

Christine Pearce

Managing Editor, PsycCRITIQUES

Reviewer Guidelines and Forms available at

http://www.apa.org/pubs/databases/psyccritiques/reviewer-guidelines.aspx

 

Editorial Office mailing address:

Christoph Zepeda, Editorial Assistant, PsycCRITIQUES

California School of Professional Psychology

Alliant International University

One Beach St., Suite 200

San Francisco, CA 94133-1221

Fax: 314-754-9913

Editorial office phone: (415) 955-2177

Phone for C. Pearce in Oregon: (541) 246-8690

Journal Email: cpearce@alliant.edu (if difficulty with this email, try psyccritiques@gmail.com)

 

Visit the PsycCRITIQUES Blog: http://psyccritiquesblog.apa.org/

and comment on or read featured reviews

 

[DIV28SUPER] FW: Postdoctoral opportunity for trainees

A postdoctoral training position is available in the Committee on the Neurobiology of Addictive Disorders
(http://www.scripps.edu/research/cnad/) at The Scripps Research Institute (www.scripps.edu). The trainee will benefit from a vibrant research environment in CNAD which houses the laboratories of multiple investigators focused on topics related to substance abuse. The Taffe laboratory will serve as the primary training environment but collaborative work with one or more of our ongoing collaborators is expected. Current projects in the laboratory focus on the reinforcing, addictive and toxic effects of psychomotor stimulants, including novel cathinone derivatives, of the exogenous cannabinoids/cannabimimetics and of prescription opioids in rodent models. In addition to basic behavioral and neurobiological consequences, the group investigates the potential of anti-drug vaccination and/or physical exercise to moderate drug effects.

Applicants should have a recent doctoral degree in neuroscience, behavioral pharmacology, experimental psychology or related field and a strong interest in substance abuse research. An ability to think critically and creatively, along with strong writing and communication skills is essential. Previous experience with /in vivo/ rodent models is preferred, but not essential. Applications will be accepted until the position is filled. /The Scripps Research Institute is an equal opportunity employer and individuals underrepresented in the field are especially encouraged to apply./

Please send a cover letter, CV and contact information for three references to Dr. Taffe (mtaffe@scripps.edu).

--
Michael A. Taffe, Ph.D.
Associate Professor
Committee on the Neurobiology of Addictive Disorders Mailcode SP30-2400 The Scripps Research Institute
10550 North Torrey Pines Road
La Jolla CA 92037
ph. 858.784.7228; fax: 858.784.7405
http://www.scripps.edu/cnad/taffe/

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

[DIV28SUPER] Summer Institute on Innovative Methods

Announcing the 2014 Methodology Center Summer Institute on Innovative Methods:

 

Experimental Design and Analysis Methods for Developing Adaptive Interventions: Getting SMART

 

We are pleased to announce that Drs. Daniel Almirall and Inbal "Billie" Nahum-Shani, Methodology Center researchers at the University of Michigan, will be teaching this year's Summer Institute on Innovative Methods, "Experimental Design and Analysis Methods for Developing Adaptive Interventions: Getting SMART."  Sponsored by Penn State'sMethodology Center and the National Institute on Drug Abuse, the 19th Summer Institute will introduce adaptive interventions; provide the background needed to plan a sequential, multiple assignment, randomized trial (SMART); and present the data analysis methods needed to construct adaptive interventions using SMART study data.

The institute will be held June 19-20, 2014, at the University of Michigan in Ann Arbor, Michigan.  Please visithttp://methodology.psu.edu/summerinstitute/ to learn more and submit your application. The deadline for applications isMarch 31.

 

Background

 

The management of many health disorders often entails a sequential, individualized approach whereby treatment is adapted and re-adapted over time in response to the specific needs and evolving status of the individual. Adaptive interventions provide one way to operationalize the strategies (e.g., continue, augment, switch, step-down) leading to individualized sequences of treatment. An adaptive intervention is a sequence of decision rules that specify whether, how or when (timing) to individualize treatment in the course of an individual's care. Often, a wide variety of critical questions must be answered when developing a high-quality adaptive intervention. Yet, there is often insufficient empirical evidence or theoretical basis to address these questions. The sequential, multiple assignment, randomized trial (SMART)—a type of research design—was developed explicitly for the purpose of building high-quality adaptive interventions. SMART designs represent an attractive alternative to the standard randomized clinical trial when the overarching aim is to construct (as opposed to evaluate) a high-quality adaptive intervention.

Sample of Topics to be Covered

• When and why adaptive interventions are needed
• The critical components of adaptive interventions: decision points, tailoring variables, intervention options and decision rules
• SMART study principles, including how to provide a rationale for designing a SMART
• Data analytic strategies used to examine primary and secondary scientific aims in a SMART

In addition to the above topics, several hands-on computer exercises will be woven throughout the lecture, and time will be reserved for question/answer periods and open discussion.  

 

Learn More

 

http://methodology.psu.edu/summerinstitute/

Katie Bode-Lang, Assistant Director
The Methodology Center · Penn State University
400 Calder Square II · University Park, PA 16802
Phone: 814.867.0333 · kbodelang@psu.edu
Web: http://methodology.psu.edu

[DIV28SUPER] NIDA Neuroscience Update, March 10, 2014

Table of contents

I.                    NOT-RM-14-007 Input on Future Directions for the Science of Behavior Change Common Fund Program

II.                  BARCELONA 2014 Summer Course "Cellular Biology of Addiction" (partnered with the CSHL), July 13-20, 2014 

III.                Notice that NIDA's "Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects" Funding Opportunity Announcements Have Been Reposted as PARs

IV.                Tools for Monitoring and Manipulating Modified RNAs in the Nervous System (R43/R44) 

V.                  Tools for Monitoring and Manipulating Modified RNAs in the Nervous System (R41/R42)

VI.                Neuroimmune Signaling and Function in Substance Use Disorders (R01) and (R21)

VII.              Identification of Gene Variants for Addiction Related Traits by Next-Gen Sequencing in Model Organisms Selectively Bred for Addiction Traits (UH2/UH3)

VIII.       Notice of Participation of the National Institute on Drug Abuse in RFA-HG-14-020 "Development of Software and Analysis Methods for Biomedical Big Data in Targeted Areas of High Need (U01)"

 

 

I.        NOT-RM-14-007 Input on Future Directions for the Science of Behavior Change Common Fund Program http://grants.nih.gov/grants/guide/notice-files/NOT-RM-14-007.html Responses are due by March 20, 2014

The NIH Common Fund Science of Behavior Change (SOBC) Program has sought to transcend disciplinary and disease-specific boundaries through a focus on mechanisms of behavior change. The SOBC Program seeks input to aid in shaping the directions for potential future investments and is soliciting input from members of the extramural research community working in any area of science relevant to behavior change. We also encourage input from stakeholders who: represent research communities focused on a range of diseases or conditions for which behavior change is relevant, are at all stages of career development, or are working at any point on the basic to applied continuum. Input is also requested from groups and organizations with an interest in understanding behavior and intervening to promote and sustain behavior change for purposes of health promotion, health maintenance, disease management, and disease prevention.

--------------------------

II.      BARCELONA 2014 Summer Course "Cellular Biology of Addiction" (partnered with the CSHL), July 13-20, 2014  Barcelona Biomedical Research Park (PRBB), c/ Dr Aiguader, 88, 08003 Barcelona, Spain

 

Applications due April 4, 2014.

 

http://eventum.upf.edu/event_detail/1025/detail/barcelona-2014-summer-course-andquot;cellular-biology-of-addictionandquot;.html

 

The primary objective of the workshop is to provide an intense discussion of the fundamentals, state-of-the-art advances and major gaps in the cell and molecular biology of drug addiction. Targeted to both new and experienced investigators, the workshop will combine formal presentations and informal discussions to convey the merits and excitement of cellular and molecular approaches to drug addiction research.

--------------------------

 

III.  Notice that NIDA's "Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects" Funding Opportunity Announcements Have Been Reposted as PARs  http://grants.nih.gov/grants/guide/notice-files/NOT-DA-14-006.html

 

--------------------------

IV.    Tools for Monitoring and Manipulating Modified RNAs in the Nervous System (R43/R44)  http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-001.html

(RFA-DA-15-001)
National Institute on Drug Abuse
Application Receipt Date(s): April 24, 2014

The purpose of this initiative is to incentivize small businesses to generate tools and products specifically for monitoring and manipulating covalently modified eukaryotic mRNAs and regulatory RNAs.

-----------------

V.      Tools for Monitoring and Manipulating Modified RNAs in the Nervous System (R41/R42) http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-002.html

(RFA-DA-15-002)
National Institute on Drug Abuse
Application Receipt Date(s): April 24, 2014

The purpose of this initiative is to incentivize small businesses to generate tools and products specifically for monitoring and manipulating covalently modified eukaryotic mRNAs and regulatory RNAs.

--------------

 

VI.    Neuroimmune Signaling and Function in Substance Use Disorders (R01) and (R21)

https://grants.nih.gov/grants/guide/pa-files/PA-14-084.html and http://grants.nih.gov/grants/guide/pa-files/PA-14-083.html

The purpose of this Funding Opportunity Announcement (FOA) is to encourage the submission of research project grant applications that propose to examine the molecular, cellular, circuit, and behavioral responses to neuroimmune signaling within the central nervous system (CNS) as it pertains to the initiation, escalation, and maintenance of, and the neurological consequences resulting from, substance use disorders (SUDs), and to abstinence and withdrawal from, and subsequent relapse of, drug use. The goal of this understudied area of research is to determine the extent to which neuroimmune responses contribute to or protect against current and future risk and consequences of SUDs. 

 

-----------------

 

VII.  Identification of Gene Variants for Addiction Related Traits by Next-Gen Sequencing in Model Organisms Selectively Bred for Addiction Traits (UH2/UH3) http://grants.nih.gov/grants/guide/pa-files/PAR-14-010.html  Next application date June 30, 2014

The goals of this initiative are to: 1) develop strategies and methodologies for the sequencing, mapping and genomic analyzing of established phenotypes of selectively bred animal models with addiction traits, and 2) identify, from new or existing selectively bred animal models, genetic variants with implications for addiction related traits.  

 

----------------

 

VIII. Notice of Participation of the National Institute on Drug Abuse in RFA-HG-14-020 "Development of Software and Analysis Methods for Biomedical Big Data in Targeted Areas of High Need (U01)"

 

NIDA has joined, RFA-HG-14-020, "Development of Software and Analysis Methods for Biomedical Big Data in Targeted Areas of High Need (U01)". In response to the spectacular opportunities and immense challenges presented by the dawning era of "Big Data" in biomedical research, the NIH has developed the Big Data to Knowledge (BD2K) initiative. The purpose of this BD2K U01 Funding Opportunity Announcement (FOA) is to solicit development of innovative analytical methods and software tools in the four topic areas of data compression/reduction, data visualization, data provenance, and data wrangling as part of the overall BD2K initiative. It is not expected that software and methods developed under this FOA will be fully hardened, but rather that investigators show a novel approach to a difficult problem and show some proof-of-concept for this new approach using relevant biomedical Big Data. There is no PI citizenship restriction. Foreign institutions are not eligible, but foreign components are allowed. It has a single submission date, May 19, 2014 and earliest funding will begin in March 2015. The projects may last for three years. Annual direct costs are a maximum of $300K. Please see our notice of participation at: http://grants.nih.gov/grants/guide/notice-files/NOT-DA-14-008.html.

 

---------------------

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to istserv@list.nih.govmailto:listserv@list.nih.gov,

 Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov     301-435-1309

[DIV28SUPER] NYTimes: E-Cigarettes, by Other Names, Lure Young and Worry Experts

http://nyti.ms/1kVMEOm

Products virtually identical to e-cigarettes are known by names like e-hookahs or vaping pens, thwarting efforts by health officials to track their use, especially among young people.


Sent from my iPad
___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

[DIV28SUPER] NYTimes: Regulating Electronic Cigarettes

http://nyti.ms/1od7SaI

European lawmakers have adopted strong and balanced rules for nicotine-delivery devices.


Sent from my iPad
___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org